gag Gene Products, Human Immunodeficiency Virus
"gag Gene Products, Human Immunodeficiency Virus" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Proteins encoded by the GAG GENE of the HUMAN IMMUNODEFICIENCY VIRUS.
| Descriptor ID |
D054301
|
| MeSH Number(s) |
D12.776.775.330.650 D12.776.964.775.350.362 D12.776.964.775.562.750 D12.776.964.970.600.850.350.362
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "gag Gene Products, Human Immunodeficiency Virus".
Below are MeSH descriptors whose meaning is more specific than "gag Gene Products, Human Immunodeficiency Virus".
This graph shows the total number of publications written about "gag Gene Products, Human Immunodeficiency Virus" by people in this website by year, and whether "gag Gene Products, Human Immunodeficiency Virus" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 0 | 1 | 1 |
| 2002 | 0 | 1 | 1 |
| 2009 | 0 | 1 | 1 |
| 2011 | 0 | 2 | 2 |
| 2012 | 2 | 0 | 2 |
| 2013 | 1 | 0 | 1 |
| 2016 | 1 | 1 | 2 |
| 2017 | 13 | 6 | 19 |
| 2018 | 12 | 7 | 19 |
| 2019 | 1 | 1 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "gag Gene Products, Human Immunodeficiency Virus" by people in Profiles.
-
Characterization of HIV-1 virus-like particles and determination of Gag stoichiometry for different production platforms. Biotechnol Bioeng. 2021 07; 118(7):2660-2675.
-
Phosphate Derivatives of 3-Carboxyacylbetulin: SynThesis, In Vitro Anti-HIV and Molecular Docking Study. Biomolecules. 2020 08 05; 10(8).
-
New mechanisms of resistance in virological failure to protease inhibitors: selection of non-described protease, Gag and Gp41 mutations. J Antimicrob Chemother. 2019 07 01; 74(7):2019-2023.
-
HIV-1 protease, Gag and gp41 baseline substitutions associated with virological response to a PI-based regimen. J Antimicrob Chemother. 2019 06 01; 74(6):1679-1692.
-
Lymphomagenic properties of a HIV p17 variant derived from a splenic marginal zone lymphoma occurred in a HIV-infected patient. Hematol Oncol. 2019 Apr; 37(2):176-184.
-
p17 from HIV induces brain endothelial cell angiogenesis through EGFR-1-mediated cell signalling activation. Lab Invest. 2019 02; 99(2):180-190.
-
Human immunodeficiency virus 1 dual-target nucleic acid technology improves blood safety: 5 years of experience of the German Red Cross blood donor service Baden-Württemberg-Hessen. Transfusion. 2018 12; 58(12):2886-2893.
-
Identification of amino acid residues critical for the B cell growth-promoting activity of HIV-1 matrix protein p17 variants. Biochim Biophys Acta Gen Subj. 2019 01; 1863(1):13-24.
-
Safety and tolerability of HIV-1 multiantigen pDNA vaccine given with IL-12 plasmid DNA via electroporation, boosted with a recombinant vesicular stomatitis virus HIV Gag vaccine in healthy volunteers in a randomized, controlled clinical trial. PLoS One. 2018; 13(9):e0202753.
-
High-resolution structures of HIV-1 Gag cleavage mutants determine structural switch for virus maturation. Proc Natl Acad Sci U S A. 2018 10 02; 115(40):E9401-E9410.